Barrow, Hanley, Mewhinney & Strauss’s Ingevity NGVT Stock Holding History
Bought
Maintained
Sold
Other funds holding NGVT
VPM
VCM
SBH
SCM
Barrow, Hanley, Mewhinney & Strauss's NGVT Position: Q1 2026 in Review
Barrow, Hanley, Mewhinney & Strauss held its Ingevity (NGVT) position steady in Q1 2026 at 45 shares worth $3.21K. The position accounts for ﹤0.01% of the portfolio, ranked #303.
Barrow, Hanley, Mewhinney & Strauss first reported a position in NGVT in Q4 2019 and has held it in 19 quarters since. The position peaked at $1.28M in Q2 2020. 307 funds tracked by Wall St. Rank hold NGVT as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss held 45 shares of Ingevity worth $3.21K as of Q1 2026.
- Barrow, Hanley, Mewhinney & Strauss left its Ingevity share count unchanged in Q1 2026.
- Ingevity made up ﹤0.01% of Barrow, Hanley, Mewhinney & Strauss's portfolio in Q1 2026, its #303 holding.
- Barrow, Hanley, Mewhinney & Strauss first reported a position in Ingevity in Q4 2019 and has held it in 19 quarters since.
- Barrow, Hanley, Mewhinney & Strauss's Ingevity position peaked at $1.28M in Q2 2020.
- 307 funds tracked by Wall St. Rank held Ingevity as of Q1 2026.
Based on Barrow, Hanley, Mewhinney & Strauss's 13F filing for Q1 2026, filed 13 May 2026.